Clorox CLX Balance Sheet Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $1.19B+418% | $229M-22.1% | $169M-40.1% | $170M-17.9% | $229M+3.6% | ||
| $671M+12.4% | $671M+11.3% | $703M+18.2% | $821M+18.1% | $597M-11.3% | ||
| $588M— | $608M— | $577M— | $523M+26,050% | $0-100% | ||
| $151M+4.1% | $155M+3.3% | $149M+0.7% | $141M-18.0% | $145M-19.0% | ||
| $23M+9.5% | $18M+12.5% | $18M+50.0% | $15M+66.7% | $21M+75.0% | ||
| $489M-11.6% | $519M+1.8% | $500M-3.5% | $447M-19.6% | $553M-6.0% | ||
| $205M+55.3% | $222M+51.0% | $249M+128% | $97M+10.2% | $132M+38.9% | ||
| $2.65B+66.7% | $1.73B+5.9% | $1.7B+7.6% | $1.61B-0.9% | $1.59B-4.3% | ||
| $1.24B-0.8% | $1.25B+0.4% | $1.25B+0.7% | $1.27B-3.7% | $1.25B-3.6% | ||
| $3.04B+6.0% | $3.01B+6.2% | $2.96B+5.6% | $2.91B+3.2% | $2.87B+2.6% | ||
| $355M+1.7% | $368M+1.7% | $318M-6.7% | $333M-7.5% | $349M-7.9% | ||
| $1.23B+0.6% | $1.23B+1.0% | $1.23B-0.5% | $1.23B+0.1% | $1.22B-0.6% | ||
| $49M-27.9% | $54M-26.0% | $59M-24.4% | $64M-55.2% | $68M-54.4% | ||
| $23M+9.5% | $19M-13.6% | $20M-13.0% | $20M-9.1% | $21M-12.5% | ||
| $415M-22.7% | $483M-11.9% | $476M-9.2% | $558M+2.4% | $537M-3.4% | ||
| $6.44B+16.8% | $5.61B+0.6% | $5.53B+0.6% | $5.56B-3.3% | $5.51B-5.0% | ||
| $1.48B-26.6% | $1.96B+34.0% | $1.93B+30.9% | $1.83B+23.0% | $2.02B+22.0% | ||
| $28M+3.7% | $27M-3.6% | $27M-3.6% | $27M-3.6% | $27M-3.6% | ||
| $1.59B+2,846% | $307M+62.4% | $218M+5,350% | $4M0.0% | $54M-51.4% | ||
| $85M0.0% | $83M+2.5% | $89M+7.2% | $87M+3.6% | $85M+3.7% | ||
| $3.16B+46.4% | $2.35B+35.7% | $2.23B+41.5% | $1.92B+21.9% | $2.16B+16.7% | ||
| $2.49B+0.2% | $2.49B+0.1% | $2.49B+0.1% | $2.48B+0.1% | $2.48B+0.1% | ||
| $323M+0.3% | $341M+0.6% | $286M-9.2% | $305M-8.7% | $322M-7.2% | ||
| $356M+4.4% | $385M-56.3% | $365M-58.2% | $351M-58.6% | $341M-60.0% | ||
| $6.34B+19.2% | $5.58B+2.2% | $5.39B+2.2% | $5.08B-3.4% | $5.32B-4.1% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| 750M0.0% | 750M0.0% | 750M0.0% | 750M+473% | 750M0.0% | ||
| $1.32B+0.8% | $1.3B+1.3% | $1.33B+2.2% | $1.32B+2.4% | $1.3B+2.7% | ||
| $223M+125% | $190M+179% | $200M+545% | $432M+72.8% | $99M+191% | ||
| -$152M+13.6% | -$159M+12.2% | -$165M-12.2% | -$157M-1.3% | -$176M-13.5% | ||
| $1.58B+19.0% | $1.59B+18.2% | $1.51B+20.9% | $1.4B+18.4% | $1.33B+11.9% | ||
| $159M-2.5% | $160M-1.2% | $160M-2.4% | $161M-1.8% | $163M-0.6% | ||
| -$67M-348% | -$125M-205% | -$22M-137% | $321M-2.1% | $27M-70.3% | ||
| $6.44B+16.8% | $5.61B+0.6% | $5.53B+0.6% | $5.56B-3.3% | $5.51B-5.0% | ||
| $489M-11.6% | $519M+1.8% | $500M-3.5% | $447M-19.6% | $553M-6.0% | ||
| $151M+4.1% | $155M+3.3% | $149M+0.7% | $141M-18.0% | $145M-19.0% | ||
| $75M-10.7% | $84M0.0% | $90M+7.1% | $80M-18.4% | $84M-19.2% | ||
| $415M-22.7% | $483M-11.9% | $476M-9.2% | $558M+2.4% | $537M-3.4% | ||
| $355M+1.7% | $368M+1.7% | $318M-6.7% | $333M-7.5% | $349M-7.9% | ||
| $355M+1.7% | $368M+1.7% | $318M-6.7% | $333M-7.5% | $349M-7.9% | ||
| $415M-22.7% | $483M-11.9% | $476M-9.2% | $558M+2.4% | $537M-3.4% | ||
| $49M-27.9% | $54M-26.0% | $59M-24.4% | $64M-55.2% | $68M-54.4% | ||
| $502M+0.2% | $502M+0.2% | $502M-0.2% | $502M-6.7% | $501M-7.1% | ||
| $355M+1.7% | $368M+1.7% | $318M-6.7% | $333M-7.5% | $349M-7.9% | ||
| $415M-22.7% | $483M-11.9% | $476M-9.2% | $558M+2.4% | $537M-3.4% | ||
| $28M+3.7% | $27M-3.6% | $27M-3.6% | $27M-3.6% | $27M-3.6% | ||
| $0— | $0— | $0— | —— | $0— | ||
| $1.48B-26.6% | $1.96B+34.0% | $1.93B+30.9% | $1.83B+23.0% | $2.02B+22.0% | ||
| 18,500,000,000%-4,200,000,000% | 19,800,000,000%-2,000,000,000% | 17,900,000,000%-4,000,000,000% | 23,600,000,000%+3,100,000,000% | 22,700,000,000%+1,900,000,000% | ||
| $4.49B+52.4% | $3.22B+4.0% | $3.08B+6.7% | $2.92B-0.7% | $2.94B-2.5% | ||
| $1.000.0% | $1.000.0% | $1.000.0% | $1.000.0% | $1.000.0% | ||
| 130.7M0.0% | 130.7M0.0% | 130.7M0.0% | 130.7M0.0% | 130.7M0.0% | ||
| 5M0.0% | 5M0.0% | 5M0.0% | 5M0.0% | 5M0.0% | ||
| 0— | 0— | 0— | 0— | 0— | ||
| 0— | 0— | 0— | 0— | 0— | ||
| $1.32B+0.8% | $1.3B+1.3% | $1.33B+2.2% | $1.32B+2.4% | $1.3B+2.7% | ||
| $131M0.0% | $131M0.0% | $131M0.0% | $131M0.0% | $131M0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $1.000.0% | $1.000.0% | $1.000.0% | $1.000.0% | $1.000.0% | ||
| $28M+3.7% | $27M-3.6% | $27M-3.6% | $27M-3.6% | $27M-3.6% | ||
| $1.59B+2,846% | $307M+62.4% | $218M+5,350% | $4M0.0% | $54M-51.4% | ||
| $10.0% | $10.0% | $10.0% | $10.0% | $10.0% | ||
| $750M0.0% | $750M0.0% | $750M0.0% | $750M0.0% | $750M0.0% | ||
| $130.74M0.0% | $130.74M0.0% | $130.74M0.0% | $130.74M0.0% | $130.74M0.0% | ||
| $120.92M-1.9% | $120.89M-1.8% | $121.78M-1.5% | $122.69M-1.2% | $123.25M-0.8% | ||
| $23M+9.5% | $19M-13.6% | $20M-13.0% | $20M-9.1% | $21M-12.5% | ||
| $0— | $1M— | $0-100% | $2M— | $0— | ||
| $588M-7.4% | $608M+2.7% | $577M-2.9% | $523M-18.2% | $635M-5.9% | ||
| $18M0.0% | $18M0.0% | $20M+11.1% | —— | $18M— | ||
| $0— | $0— | $0— | —— | $0— | ||
| $159M-2.5% | $160M-1.2% | $160M-2.4% | $161M-1.8% | $163M-0.6% | ||
| $10.0% | $10.0% | $10.0% | $10.0% | $10.0% | ||
| $5M0.0% | $5M0.0% | $5M0.0% | $5M0.0% | $5M0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $9.82M+31.1% | $9.85M+29.8% | $8.97M+26.9% | $8.05M+23.1% | $7.49M+14.3% | ||
| —— | $476M— | $476M— | $476M— | —— | ||
| —— | $476M-7.9% | $488M— | $501M-1.8% | $515M— | ||
| 4%-0.6% | —— | —— | 4.6%-1.0% | 4.6%— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Clorox's total assets?
- Clorox (CLX) holds $6.4B in total assets, up 16.8% year over year.
- How much debt does Clorox have?
- Clorox carries $4.5B in total debt against -$67.0M of shareholders' equity, a debt-to-equity ratio of 9.08.
- How much cash does Clorox have?
- Clorox holds $1.2B in cash and equivalents.
- Can Clorox cover its short-term obligations?
- Its current ratio is 0.84 — current liabilities exceed current assets.
- Where does Clorox's balance sheet data come from?
- Every line is extracted from Clorox's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
